Methylprednisolone acetate vs Certolizumab pegol
National NHS prescribing compared (Prescription Cost Analysis)
Methylprednisolone acetate was dispensed 70,715.0× as often as Certolizumab pegol in May 2026 — 70,715 items versus 1 in England.
70,715items
Methylprednisolone acetate · May 2026
NHSBSA Prescription Cost Analysis
1items
Certolizumab pegol · May 2026
NHSBSA Prescription Cost Analysis
Figure 1. Methylprednisolone acetate versus Certolizumab pegol: national items dispensed by month
▬ Methylprednisolone acetate · ╌ Certolizumab pegol
Source: NHSBSA Prescription Cost Analysis, to May 2026
| Measure | Methylprednisolone acetate | Certolizumab pegol |
|---|---|---|
| Items, May 2026 | 70,715 | 1 |
| Items, last 12 months | 749,895 | 6 |
| Net ingredient cost, May 2026 | £353,654 | £358 |
See the full profile for Methylprednisolone acetate or Certolizumab pegol.